Medicilon organized The 5th Advanced Training Course for Non clinical Safety Evaluation of Drugs

著者：medicilon   アップロード：2019-08-22  閲読回数：

On August 16-19, 2019, Shanghai Medicilon Inc. successfully organized The 5th Advanced Training Course for Non-clinical Safety Evaluation of Drugs for Study Director, which hosted by Drug Safety Evaluation Research Committee of China Pharmaceutical Association and National Institutes for Food and Drug Control.  The training course lasted for 2 days and 13 experts were invited to give a speech. There were nearly 300 people to attend the training course.

Currently, China’s safety evaluation agencies have entered a period of rapid development, and the ranks and scale of personnel have been continuously expanded. Therefore, the new SD requires a new and better platform for exchange and development.  In order to further promote the improvement of SD in the field of drug safety evaluation in China and promote the improvement of the overall capacity of China’s drug safety evaluation industry, the training course was based on the topic of “Non-Clinical Safety Evaluation of New Drug” and invited authoritative experts in the field of evaluation, experts in centers for drug evaluation, and senior SD in China to give a speech on approval strategy of new biological products and safety evaluation case analysis.

The 5th Advanced Training Course for Non-clinical Safety Evaluation of Drugs for Study Director

Non-Clinical Safety Evaluation of New Drug

上の：The Preclinical Research of Innovative Drug Seminar was successfully held in Beijing

下に：Medicilon pushes on preclinical development of drugs